Moleculin Biotech, Inc. (MBRX)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Moleculin Biotech, Inc. reported revenue of $0. The company ran a net loss. It held $22.13M in total assets against $7.12M in total liabilities.
Key ratios (FY2025)
-223.6%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — |
| Operating Income | -$25.10M | -$26.64M | -$29.63M | -$30.64M | -$22.97M | -$19.74M | -$17.52M | -$15.03M | -$8.65M | -$3.88M |
| Net Income | -$33.56M | -$26.05M | -$29.77M | -$29.02M | -$15.89M | -$17.36M | -$13.21M | -$11.88M | -$9.80M | -$3.93M |
| EPS (Diluted) | $-28.42 | $-189.14 | $-15.07 | $-15.22 | $-0.59 | — | — | — | — | — |
| Total Assets | $22.13M | $16.93M | $38.22M | $57.42M | $84.09M | $29.03M | $25.23M | $19.59M | $19.48M | $16.39M |
| Total Liabilities | $7.12M | $5.72M | $12.14M | $5.23M | $5.10M | $11.27M | $9.66M | $5.31M | $2.37M | $1.43M |
| Shareholders' Equity | $15.01M | $11.21M | $30.93M | $52.19M | $78.99M | $17.76M | $15.57M | $14.27M | $17.12M | $14.96M |
| Cash & Equivalents | $8.88M | $4.28M | $23.55M | $43.15M | $70.90M | $15.17M | $10.73M | $7.13M | $7.71M | $5.01M |
| Operating Cash Flow | -$22.73M | -$23.86M | -$23.59M | -$27.64M | -$18.95M | -$17.77M | -$17.20M | -$12.20M | -$7.32M | -$3.77M |
| Capital Expenditures | $0 | $13.0K | $124.0K | $67.0K | $19.0K | $376.0K | $52.0K | $417.0K | $28.0K | $21.0K |
| Shares Outstanding | 3.20M | 135.2K | 2.23M | 1.91M | 28.58M | 11.54M | 7.62M | 28.53M | 21.47M | 12.16M |